Latest news
Cartesian Therapeutics Reports Q2 2026 Results, Advances Descartes-08 Clinical Trials and WestGene In Vivo Partnership - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:15:00 GMTCartesian Therapeutics reports Q2 2026: $149.3M cash; net income $15.8M; Phase 3 MG data expected 1Q27 - TradingViewTradingView · Thu, 06 Aug 2026 11:13:01 GMTDescartes (TSX:DSG) Delivers Steady Progress Within Growth Stocks - Kalkine MediaKalkine Media · Tue, 04 Aug 2026 19:00:00 GMTLarge-Scale Brain Models - Trend HunterTrend Hunter · Mon, 03 Aug 2026 09:05:43 GMT